Breaking News

Univercells Technologies Appoints Florence Vicaire as Chief Commercial Officer

Vicaire will be responsible for the commercialization and continued expansion of the company’s enabling portfolio of biomanufacturing technologies and services.

Author Image

By: Charlie Sternberg

Associate Editor

Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable production of advanced therapies, has appointed Florence Vicaire as chief commercial officer (CCO).   In this newly created role, Vicaire will be responsible for the commercialization and continued expansion of the company’s enabling portfolio of biomanufacturing technologies and services, which include the scale-X and NevoLine platforms.   “This appointment reflects our commitment to strate...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters